Avid Organics to launch bio-based glycolic acid at in-cosmetics Global
Last update on Mar 26, 2026
Avid Organics, India’s manufacturer of glycolic acid, will unveil AviGa™ Bio HP70, one of the first bio-based glycolic acids to reach commercial scale globally, at in-cosmetics® Global in Paris on April 14, 2026.
Produced entirely from plant-based feedstocks, the product is supported by advanced manufacturing infrastructure powered by 100% renewable energy, REACH registration for European markets, and Avid’s 18-year track record serving regulated industries across the world.
For more information on Avid Organics' latest developments, visit their profile!
70% cosmetic-grade solution meeting stringent purity requirements
AviGa™ Bio HP70 is a 70% cosmetic-grade solution meeting stringent purity requirements for regulated personal care, cosmetics, and pharmaceutical applications. Manufacturing processes ensure rigorous control of trace impurities, including formaldehyde, methoxyacetic acid, and dichloroacetic acid - commonly associated with petroleum-based glycolic acid. The product offers formulators a like-for-like technical replacement while enabling meaningful sustainability claims.
Glycolic acid is one of the most consequential actives in modern skincare. As the smallest and most skin-penetrating alpha-hydroxy acid, it underpins a global anti-aging market worth millions of dollars and is used across over-the-counter skincare, haircare, professional chemical peels, and pharmaceutical formulations. Despite its ubiquity, conventional glycolic acid has long been produced from fossil fuels.
Want to know about Glycolic acid? See details here!
Traditional production relies on carbonylation of formaldehyde, a process dependent on natural gas and associated with measurable trace contaminants. As the personal care industry accelerates its transition toward cleaner and more sustainable supply chains, the need for commercially scalable, bio-based glycolic acid has intensified. However, such solutions have remained largely inaccessible to global formulators.